Annual Total Liabilities
$153.99 M
+$806.00 K+0.53%
December 31, 2024
Summary
- As of March 1, 2025, VERV annual total liabilities is $153.99 million, with the most recent change of +$806.00 thousand (+0.53%) on December 31, 2024.
- During the last 3 years, VERV annual total liabilities has risen by +$127.22 million (+475.20%).
- VERV annual total liabilities is now at all-time high.
Performance
VERV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$153.99 M
-$1.36 M-0.88%
December 31, 2024
Summary
- As of March 1, 2025, VERV quarterly total liabilities is $153.99 million, with the most recent change of -$1.36 million (-0.88%) on December 31, 2024.
- Over the past year, VERV quarterly total liabilities has increased by +$806.00 thousand (+0.53%).
- VERV quarterly total liabilities is now -34.36% below its all-time high of $234.60 million, reached on March 31, 2021.
Performance
VERV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VERV Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.5% | +0.5% |
| 3 y3 years | +475.2% | +1.3% |
| 5 y5 years | +273.8% | +1.3% |
VERV Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +475.2% | -0.9% | +762.6% |
| 5 y | 5-year | at high | +475.2% | -34.4% | +762.6% |
| alltime | all time | at high | +475.2% | -34.4% | +762.6% |
Verve Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $153.99 M(+0.5%) | $153.99 M(-0.9%) |
| Sep 2024 | - | $155.35 M(+0.3%) |
| Jun 2024 | - | $154.82 M(+3.7%) |
| Mar 2024 | - | $149.29 M(-2.5%) |
| Dec 2023 | $153.19 M(+19.4%) | $153.19 M(+0.8%) |
| Sep 2023 | - | $152.04 M(+22.7%) |
| Jun 2023 | - | $123.91 M(-0.8%) |
| Mar 2023 | - | $124.90 M(-2.6%) |
| Dec 2022 | $128.29 M | $128.29 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $125.41 M(+349.0%) |
| Jun 2022 | - | $27.93 M(+56.5%) |
| Mar 2022 | - | $17.85 M(-33.3%) |
| Dec 2021 | $26.77 M(-81.2%) | $26.77 M(+3.2%) |
| Sep 2021 | - | $25.94 M(+22.8%) |
| Jun 2021 | - | $21.12 M(-91.0%) |
| Mar 2021 | - | $234.60 M(+64.8%) |
| Dec 2020 | $142.32 M(+245.4%) | - |
| Dec 2020 | - | $142.32 M |
| Dec 2019 | $41.20 M | - |
FAQ
- What is Verve Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Verve Therapeutics?
- What is Verve Therapeutics annual total liabilities year-on-year change?
- What is Verve Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Verve Therapeutics?
- What is Verve Therapeutics quarterly total liabilities year-on-year change?
What is Verve Therapeutics annual total liabilities?
The current annual total liabilities of VERV is $153.99 M
What is the all time high annual total liabilities for Verve Therapeutics?
Verve Therapeutics all-time high annual total liabilities is $153.99 M
What is Verve Therapeutics annual total liabilities year-on-year change?
Over the past year, VERV annual total liabilities has changed by +$806.00 K (+0.53%)
What is Verve Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VERV is $153.99 M
What is the all time high quarterly total liabilities for Verve Therapeutics?
Verve Therapeutics all-time high quarterly total liabilities is $234.60 M
What is Verve Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VERV quarterly total liabilities has changed by +$806.00 K (+0.53%)